Pharmacokinetics and tissue penetration of ciprofloxacin - Wikidata - awgldk - TriplyDB

Pharmacokinetics and tissue penetration of ciprofloxacin

Pharmacokinetics and tissue penetration of ciprofloxacin

http://www.wikidata.org/entity/Q41843132

about

Pharmacokinetics and inflammatory fluid penetration of sparfloxacin Pharmacokinetics and tissue penetration of enoxacin Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus Comparative antimycobacterial activities of the newly synthesized quinolone AM-1155, sparfloxacin, and ofloxacin Chemotherapeutics A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic.Comparison of ciprofloxacin with azlocillin plus tobramycin in the therapy of experimental Pseudomonas aeruginosa endocarditis.Interaction between ciprofloxacin and rifampin.Pharmacokinetics of ciprofloxacin in cystic fibrosis.Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics.Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis.Oral ciprofloxacin treatment for Salmonella typhimurium infection of normal and immunocompromised mice.Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project Ciprofloxacin activity in cyst fluid from polycystic kidneys.Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.Ciprofloxacin pharmacokinetics in patients with normal and impaired renal function Activities of new quinoline derivatives against genital pathogens.Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine Pharmacokinetics of ciprofloxacin after oral and parenteral administration.Open, prospective study of the clinical efficacy of ciprofloxacin.The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.Pharmacokinetics and sputum penetration of ciprofloxacin in patients with cystic fibrosis In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867)Ciprofloxacin penetration into extravascular spaces in a rabbit model.Quantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography.Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans.Tissue penetration of ciprofloxacin after single and multiple doses.Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.Ciprofloxacin biliary disposition in cholecystectomised patients with special references to HPLC and bioassay data.Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.Pharmacokinetics of temafloxacin in humans after single oral doses.Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing

P2860

Q24617511-10FF3A43-524C-474F-9E72-C533E2E2383C Q24674802-9926C786-19C0-4E48-9DAD-3ED3C0EF2A5B Q28334677-4167ED26-21B8-41FB-BC2E-D7FC6C8F93D4 Q28360184-B5269EC4-C19C-45A7-A7B1-D3CFDBA63E2D Q28361123-841FDBC9-5BD6-48DD-95D3-F8A713719311 Q28378625-B0AFCE36-4184-4222-8E32-DCEED3BB576F Q30047670-871341F2-39D0-4F9A-ADF1-D7C50114037A Q30425667-D6DF668D-96A2-4C1E-94CA-FAC852B84B05 Q30451302-EEEDDAA3-B9F2-4EB7-94F2-44202B178B47 Q33722507-223B8C3C-D7F9-4595-8284-3B0C766F34EC Q33741046-2373BA7E-C12F-41BB-A96B-6063F7B11459 Q35114178-CDD31B38-F21D-41AE-9FE7-6933D9938576 Q35245500-29D3A71F-D89F-4AF3-8C46-D19C7CA3AEF9 Q35288542-D5869BFF-FE65-4483-924F-DF71ED170B2C Q35289918-9314A483-BABE-4D64-B853-B932F1A1B7D6 Q35308712-A98B1E3A-B70B-4970-BDAF-9E75C5882600 Q35536186-3592AB7E-5615-4CC8-B2E9-7ABB0610A373 Q35539825-6648F670-5773-4211-8426-D5E017639905 Q35568919-D7FDF12A-258E-421B-AFEC-75188E08BEF6 Q35570539-9485593C-A23B-4684-A603-3D3FA7712505 Q35570563-30D6D487-1BC0-45CD-9CC1-C8AB47CD1AEB Q35570646-37763389-82EE-4CAE-9AD4-7386A38D5843 Q35571702-E7163A44-4BD1-4BC1-878E-6CD5E29816CA Q35572870-7B1DEEC7-D43D-4D85-A5D8-5AD590956C17 Q35575446-0BAFCF01-E451-4C79-A197-6C8411C60AA9 Q35640288-B3F39DC2-36E5-4E93-943A-653AA726167E Q35640637-965C22DE-F42F-4A99-97DD-FAA0DACB8132 Q35640759-D368738E-0832-4A95-8AD5-C9D19927AAD1 Q35641275-B23050E7-81EF-44EC-AAAE-006658851BEC Q35642422-5F204577-C714-4AC5-91C6-8CB0754235F8 Q35646379-B9776D5E-897F-49AB-95F2-E107F0EC0F30 Q35649002-C58EC7AD-D6F6-4365-B109-F3361FFC155A Q35760077-DE197B71-2CDC-412D-8B07-BE11507C7917 Q35760862-3A322E51-DC90-4EAF-8FEE-C6C6960D5798 Q35867292-C28D7E2E-456A-4555-ACCF-3843096528AD Q36474398-21B87893-079A-4751-99E5-5AA0B59A2F40 Q36600064-5DA5EC52-E744-438E-9FD3-22255CEDA75E Q36753040-A31F7C48-99EF-4E84-89E0-67D5CCF0EFF6 Q36754888-A2191D2D-D600-467C-A304-64C0902317AC Q36757117-B36136F1-C949-499B-BD28-A0C9714FA2E5

P2860

Pharmacokinetics and tissue penetration of ciprofloxacin

http://www.wikidata.org/entity/Q41843132

description

1983 nî lūn-bûn

@nan

1983年の論文

@ja

1983年論文

@yue

1983年論文

@zh-hant

1983年論文

@zh-hk

1983年論文

@zh-mo

1983年論文

@zh-tw

1983年论文

@wuu

1983年论文

@zh

1983年论文

@zh-cn

name

Pharmacokinetics and tissue penetration of ciprofloxacin

@en

type

label

Pharmacokinetics and tissue penetration of ciprofloxacin

@en

prefLabel

Pharmacokinetics and tissue penetration of ciprofloxacin

@en

P1433

Q41843132-6520D8DA-12DA-407C-9200-508760DFAAEC

P1476

Q41843132-A68C39A1-2A79-4664-B367-8BE334D9AA44

P2093

Q41843132-487A880B-8460-4A6A-863D-EF9670C0C293

Q41843132-6D4942AF-412A-48CB-8D01-C3BAA3CE99E7

Q41843132-DC73180C-5A7A-4665-AE23-0D3DC10314F6

P2860

Q41843132-33F3001A-6833-4028-8B24-051B6537A96E

Q41843132-53C0FFC9-0316-456B-AAB0-85C0A541418B

Q41843132-84FA1D88-4E3D-4124-8849-9B464582057B

Q41843132-F7AFC39C-E961-4F42-9AA0-752ED1F1F3B7

P304

Q41843132-8AB024DF-835C-4B7C-A3EB-03B06338C4D3

P31

Q41843132-51367B9F-6AED-4F6D-81B9-56F728184CE9

P356

Q41843132-057FA386-9820-4528-A9C8-EEB1DE4361FD

P407

Q41843132-97DC7A82-BFC7-421D-9869-65E6F740328A

P433

Q41843132-B9C9F161-C4DA-4E15-A467-6441AC39270C

P478

Q41843132-FDB05099-3F0E-44D5-A54C-04AFFED19EFD

P577

Q41843132-71A767FB-86DE-499F-B0E2-34D4B3077D56

P698

Q41843132-6F1E0EF3-59D7-48F7-8DA9-277A28CA5C63

P932

Q41843132-8D96C258-9E8C-4F7B-AB5F-BC3957205F71

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacokinetics and tissue penetration of ciprofloxacin

@en

P2093

Crump B

http://www.w3.org/2001/XMLSchema#string

Dent J

http://www.w3.org/2001/XMLSchema#string

Wise R

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatography.

Drug therapy. Clinical Pharmacokinetics (first of two parts).

Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients.

P304

784-786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.24.5.784

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

1983-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6660852

http://www.w3.org/2001/XMLSchema#string

P932

185942

http://www.w3.org/2001/XMLSchema#string